Link Pharma Chem Ltd (LINKPH) is currently trading at 26.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Link Pharma Chem Ltd is a mid-sized chemical manufacturing company founded in 1986, specializing in thionyl chloride and other chemical intermediates for pharmaceutical, agro-industrial, and specialty chemical applications. The company has a robust capacity for carrying out corrosive chemical reactions, equipped with advanced reactor technologies to meet diverse industry needs. Notable for expanding thionyl chloride production capacity from 300 TPA to 3300 TPA, indicating significant operational growth and market demand fulfillment. LPCL has a strategic buy-back arrangement with Gharda Chemicals for over 35% of its thionyl chloride capacity, ensuring steady revenue streams. The merger with a chlorinated paraffin manufacturing firm has broadened its product range and strengthened its market positioning.

Over the past 52 weeks, Link Pharma Chem Ltd has traded between a low of ₹21.00 and a high of ₹41.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Link Pharma Chem Ltd has a market capitalization of approximately 12.37. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Link Pharma Chem Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 324128159363334016.00 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 12.37 Cr, Link Pharma Chem Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Link Pharma Chem Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Link Pharma Chem Ltd is 324128159363334016.00. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.